Vaccinations are an important protection against infections.

• Individuals with immune deficiencies should discuss vaccinations with their doctor.

• Individuals with severe antibody deficiency must not receive live attenuated vaccines.

• Nurses will give advice by phone, Monday to Thursday between 9 and 14.

Timeline of vaccinations with antibody administration

• Intravenous: Vaccination a week before the next administration.

• Subcutaneous: Vaccination 2 to 3 days before the next administration.

Purpose

Antibodies are given to compensate for deficiencies or defects in the immune system, or as part of the treatment of certain autoimmune and inflammatory diseases.

Preparation

• The doctor will apply for a license to use the medicine, the pump and accessories.

• A nurse will call you for an interview.

• It is good to look at educational material and a teaching video before you first visit.

• The medicine is taken at a pharmacy and taken with you at the first appointment.

Treatment in the outpatient ward

• The education and practical instruction takes place on A3 in Fossvogur (children on 23E).

• Treatment is given weekly and subcutaneously.

• A stay of 2 to 3 hours can be expected during the first visits.

• The lessons will take place up to three times or until you are safe with home treatment.

Cost

Medicines and pumps are fully subsidised. Accessories are subsidised to 95%.

Supervision

• Questionnaire is sent through Heilsuvera before starting treatment and then every 6 months.

• Blood tests after 6 months and then annually.

• Annual interview with a specialist physician.

• Nurses are available by phone Monday to Thursday from 9 to 14.

Purpose

• Intravenous immunoglobulin (IVIG) therapy strengthens the immune system and helps the body fight infections.

• Used for individuals who lack antibodies, produce defective antibodies, or for certain autoimmune and inflammatory diseases.

Preparation

• Before starting treatment, the patient completes a questionnaire via Heilsuvera.

• The questionnaire is repeated every 6 months to monitor progress and treatment response.

Treatment

• Administered intravenously at:

  • Medical Day Unit B1

  • Haematology and Oncology Day and Outpatient Clinic (11B)

  • Rheumatology and Autoimmune Outpatient Clinic (Eiríksstaðir)

  • Children’s Day Unit (23E)

Follow-up

• Blood tests after 6 months and then annually.

• Annual consultation with a specialist.

Genotic angioedema is a rare genetic disease that causes recurrent inflammation and swelling due to defects in the regulatory protein (C1 esterase inhibitor).

Treatment

• Medicines that compensate for protein deficiency are given intravenously or subcutaneously.

• Treatment is tailored to individual needs.

• Nurses provide education, supervision and instruction during administration of medication.